ZNRF3

ZNRF3

ZNRF3 Overview

Molecule Name
E3 ubiquitin-protein ligase ZNRF3
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
Background
The transmembrane E3 ubiquitin ligase zinc and ring finger 3 (ZNRF3) is a negative feedback regulator of Wnt signalling. ZNRF3 is associated with the Wnt receptor complex, and inhibits Wnt signalling by promoting the turnover of frizzled and LRP6 and acts as a tumor suppressor in the intestinal stem cell zone by inhibiting the Wnt signaling pathway.

ZNRF3 Product List

Species
  • Human(1)
  • Rat(1)
Tag
  • His Tag(2)
Host
  • HEK293(2)
Conjugate
  • Unconjugated(2)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
ZNRF3
Human ZNRF3 Protein, His Tag (MALS & BLI verified)
Human
HEK293
MALSSDS-PAGE
BLI

$360.00

100ug
ZNRF3
Rat ZNRF3 Protein, His Tag
Rat
HEK293
SDS-PAGE

$360.00

100ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SZN-043SZN-043; SWEETS-1Phase 1 ClinicalSurrozen Inc
Hepatitis, Alcoholic; Liver Cirrhosis
Details
Customer Reviews